NCT06432114

Brief Summary

Few alternatives to addictive medical treatment exists for persons with severe mental health problems (SMHP) and anxiety, often connected to high risk of suicide. Access to effective interventions that depart in individuals' needs to cope with anxiety in everyday life is crucial to provide and desperately warranted by service users. Service users are often unaware of sensory needs, connected to anxiety outburst. The Sensory Awareness Program (SAP) is a group-based self-management intervention of 10 weeks developed to meet complex needs of regulating anxiety and related self-destructive behaviors. SAP stems from theories on sensory modulation and is an approach to manage physiological arousal associated with anxiety through self-regulated sensory-based coping strategies. International research show that sensory modulation is effective both as a method to reduce anxiety and thus restraint in acute mental health services (MHS), and also to empower users. However, much research to date focus on using sensory strategies within wards. International research and pre-studies of testing the SAP in outpatient MHS indicate that it is a promising self-management intervention to support everyday life. Earlier studies further show that users' unawareness of sensory needs triggers anxiety, and that anxiety itself is the main contributing factor for disrupting everyday life. Also, staff acknowledge sensory modulation but lack knowledge on whether programs such as SAP is effective and possible to implement. The overall aim is to investigate the effectiveness of SAP as compared to treatment as usual (TAU) among 200 outpatients. The investigators hypothesize that SAP will be more effective than TAU in terms of reduced anxiety (primary outcome) at three months follow-up. Secondary clinical and personal recovery outcomes post intervention and at three and six months follow up will also be targeted and assumed to be in favour of the SAP group. The implementation process of the SAP will also be explored.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
207

participants targeted

Target at P75+ for not_applicable anxiety

Timeline
Completed

Started Mar 2022

Longer than P75 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

April 17, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 29, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 2, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 2, 2025

Completed
Last Updated

February 6, 2026

Status Verified

February 1, 2026

Enrollment Period

3 years

First QC Date

April 17, 2024

Last Update Submit

February 4, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Becks anxiety inventory (BAI)

    The Beck Anxiety Inventory (BAI) is a self-report questionnaire measuring the severity of anxiety symptoms with 21 questions, each describing a symptom of anxiety. The participant rates each item on a scale from 0 to 3, indicating how much he/she experiences each symptom. The scores range from 0 to 63, with higher scores indicating more severe levels of anxiety.

    Before intervention, post intervention (at 3 months), 6 and 9 months

Secondary Outcomes (8)

  • Hopkins Symptom Checklist-25 (HSCL-25)

    Before intervention, post intervention (at 3 months), 6 and 9 months

  • Difficulties in Emotion Regulation scale (DERS)

    Before intervention, post intervention (at 3 months), 6 and 9 months

  • Coping Orientation of Problem Experience Inventory (COPE)

    Before intervention, post intervention (at 3 months), 6 and 9 months

  • Manchester Short Assessment of Quality of Life Scale (MANSA)

    Before intervention, post intervention (at 3 months), 6 and 9 months

  • Pearlin Mastery Scale

    Before intervention, post intervention (at 3 months), 6 and 9 months

  • +3 more secondary outcomes

Study Arms (2)

Sensory Awareness Program

EXPERIMENTAL
Behavioral: Sensory Awareness Program (SAP)Other: Treatment as usual (TAU)

Treatment as usual

OTHER
Other: Treatment as usual (TAU)

Interventions

Treatment as usual is standard psychiatric care for the target group.

Sensory Awareness ProgramTreatment as usual

SAP is a new rehabilitation program for people with severe mental health problems. SAP aims to help the target group manage anxiety outburst and live an active life through sensory modulation techniques.

Sensory Awareness Program

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsMale, female, non-binary
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be assigned to a MHS
  • Age over 18
  • Having SMHP (including a diagnosis of mood disorder, anxiety disorder, eg PTSD, panic disorder etc, and/or psychotic disorder)
  • Experience anxiety

You may not qualify if:

  • Acutely mentally unwell
  • Cognitively impaired
  • Non-Swedish speaking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Region Skåne

Helsingborg, Sweden

Location

Related Publications (1)

  • Forsberg K, Sutton D, Stjernsward S, Bejerholm U, Argentzell E. Implementation of a sensory modulation intervention in mental health outpatient services: a process evaluation study. BMC Psychiatry. 2025 Jun 5;25(1):581. doi: 10.1186/s12888-025-07034-5.

MeSH Terms

Conditions

Anxiety Disorders

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Mental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2024

First Posted

May 29, 2024

Study Start

March 1, 2022

Primary Completion

March 2, 2025

Study Completion

March 2, 2025

Last Updated

February 6, 2026

Record last verified: 2026-02

Locations